{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458780142
| IUPAC_name = 3,4-dimethyl-7-{[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]methoxy}-2''H''-chromen-2-one
| image = Atibeprone.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 153420-96-3
| ATC_prefix = None
| ATC_suffix =  
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 19004
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H18N2O3S/c1-9(2)16-19-18-15(23-16)8-21-12-5-6-13-10(3)11(4)17(20)22-14(13)7-12/h5-7,9H,8H2,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HQTNJPCZUQAYAB-UHFFFAOYSA-N
| PubChem = 179342
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 156109
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = PZV3P03F1U

<!--Chemical data-->
| C=17 | H=18 | N=2 | O=3 | S=1 
| molecular_weight = 330.40 g/mol
| smiles = O=C/2Oc3cc(OCc1nnc(s1)C(C)C)ccc3\C(=C\2C)C
}}

'''Atibeprone''' is an [[antidepressant]] which was developed in the mid-1990s, but was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA189&dq=atibeprone&pg=PA189#v=onepage&q=atibeprone&f=false}}</ref>

== References ==
{{Reflist}}

{{Antidepressants}}

[[Category:Antidepressants]]
[[Category:Coumarins]]
[[Category:Phenol ethers]]
[[Category:Thiadiazoles]]
[[Category:Abandoned drugs]]

{{nervous-system-drug-stub}}